InterWest Insurance Services
AUGUST 31, 2023
in 2024, as inflation starts hitting the cost of delivering care as well as pharmaceuticals. Pharmaceutical costs — There are two significant drug cost drivers: Specialty drugs: These are significantly more expensive than their traditional drug counterparts, often costing more than $2,000 per month per patient.
Workplace Insight
NOVEMBER 26, 2023
The report, “ Global Hiring Activity Trends & Signals – Q3 2023 ,” claims that sectors such as construction, insurance, banking & payments, technology and communications, and pharmaceuticals posted significant hybrid job roles during the third quarter (Q3) of 2023.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
InterWest Insurance Services
DECEMBER 21, 2023
These groundbreaking drugs — the most popular sold under the brand names Mounjaro, Ozempic and Wegovy — are partly to blame for overall pharmaceutical benefit costs jumping 8.3% in 2023, compared to an increase of 6.4% in 2022, according to a report by Mercer. 7% said they cover the drug with no special requirements.
InterWest Insurance Services
AUGUST 27, 2023
Weight Loss Medications: Learn how strategic plan design can help you avoid off-label utilization and manage the costs of these high-priced drugs, ensuring employee well-being without compromising your financial bottom line. Discover smart plan design for cost control in evolving markets.
AssuredPartners
JUNE 5, 2023
Over the last ten years, pharmaceutical companies have produced over 150 specialty drugs. Pharmaceutical Industry Implications / Practices More and more manufacturers are spending their research and development budget on rare diseases, oncology treatments, and prepping for specialty patent expiration.
HR Digest
SEPTEMBER 16, 2023
Pharmaceutical companies and researchers insist that costs have to remain high for the production and further research to be viable. The rising costs have been a result of increased use for the treatment of diabetes, but also a trend of utilizing the drug for weight loss. million for a shot, according to a report by The Economist.
The Workcomp Writer
FEBRUARY 2, 2022
In 2011, plaintiff was allegedly injured while working at a pharmaceutical plant owned and operated by defendants GlaxoSmithKline, LLC and Stiefel Laboratories, Inc. Here, the plaintiff was hired by Manpower and assigned to conduct inventory control at a pharmaceutical plant owned and operated by defendants. Background.
Expert insights. Personalized for you.
85 
Let's personalize your content